Histotripsy, a novel noninvasive ultrasound technique, demonstrated effective tumor control in liver cancer treatments.

• 70% of patients treated with curative intent achieved nonviable tumors at 30 and 90 days.
• Complications were rare, with only 1% classified as significant.

Targeting accuracy remains critical; improvements are expected as surgeons gain experience.

• 75% of treatments aimed for complete lesion ablation, but 74% of lesions showed nonviability at day 1, indicating a need for better targeting strategies.

The crush and clip technique for pancreatic transection in robotic distal pancreatectomy shows promise for reducing complications.

• Postoperative pancreatic fistula rates were 13% for crush and clip vs. 26% for stapler (p=0.280).
• Significant advantage in thick pancreas cases: 6% vs. 47% for crush and clip vs. stapler (p=0.013).

This technique eliminates major complications, with none seen in crush and clip cases compared to 14% in stapler cases.

• The cc technique offers a practical alternative that could enhance patient safety without increasing costs.

• Hospital stay: 8.1 days (LPD) vs 10.6 days (open), p=0.049.
• Lower intraoperative blood loss and transfusion rates in the LPD group.

These findings affirm LPD as a feasible option in resource-limited settings, enhancing patient recovery without compromising oncological safety.

• Comparable oncologic outcomes, including margin status and lymph node yield, suggest LPD’s effectiveness in cancer surgery.